Users Online: 555
Ahead of Print
» Articles published in the past year
To view other articles click corresponding year from the navigation links on the side bar.
Case Report and Literature Review
Letter to Editor
Letters to Editor
Export selected to
Show all abstracts
Show selected abstracts
Export selected to
Add to my list
Cloning and expression of full-length human insulin-like growth factor binding protein 3 (IGFBP3) in the
Emad Khodadadi, Mojtaba Panjepour, Mahdi Abbasian, Zahra Khalili Broujeni, Mohammad Reza Mofid
Adv Biomed Res
2015, 4:66 (25 March 2015)
The effect of the growth hormone on target cells is mediated by the insulin-like growth factor 1 (IGF-1). IGF-1 binds to the insulin-like growth factor binding proteins (IGFBPs) in blood and biological fluids. Considering the important application of IGBP3 as a drug component, in this research we cloned and expressed the full-length IGFBP3 in the pET-11a vector and BL21 (DE3) expression host.
Materials and Methods:
First the sequence encoding of IGFBP3 was designed based on the amino acid sequence of the protein and then by codon optimization, in order to ensure the maximum expression in
. In the next step, the synthetic DNA encoding IGFBP3 was inserted into the pUC57 vector, at the appropriate restriction sites and then subcloned in the pET-11a expression vector in the same restriction sites. The constructed vector was transformed to E. coli BL21 as an expression host and induced in the presence of IPTG for expression of the IGFBP3 protein. Protein expression was evaluated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).
Double digestion of the new plasmid (pET-11a -IGBP3) with
HI showed two bands in 873 bp and 5700 bp. To study the accurate cloning procedure, the plasmid was sequenced and its authenticity was confirmed. Also the expected protein band (31.6 kDa) was observed in SDS-PAGE analysis.
DNA fragment encoding the full-length IGFBP3 protein was accurately cloned in the pET-11a expression vector and the recombinant plasmid transformed to
BL21 (DE3) expression host. Results of the SDS-PAGE analysis verified that recombinant IGFBP3 (31.6 kDa) are successfully expressed under the control of T7 promoter. As we shown pET-11a can be successfully used for expression of the IGFBP3 protein.
[HTML Full text]
[Mobile Full text]
[Sword Plugin for Repository]
Month wise articles
Figures next to the month indicate the number of articles in that month
© Advanced Biomedical Research | Published by Wolters Kluwer -
Online since 15 January, 2012